Skip to main content
. 2017 May 26;12:41. doi: 10.1186/s13000-017-0616-5

Table 4.

Comparison of HER2 IHC positivity based on tumor-containing fragment number, biopsy specimen number, average size and tumor tissue proportion of tumor-containing fragments

Total HER2 P value
3+, n (%) Non-3+, n (%)
Total 890 100 (11.2) 790 (88.8)
Number of tumor-containing fragments 0.004*
1 51 1 (2.0) 50 (98.0)
2 85 3 (3.5) 82 (96.5)
3 171 12 (7.0) 159 (93.0)
4 348 46 (13.2) 302 (86.8)
5 117 20 (17.1) 97 (82.9)
6 113 18 (15.9) 95 (84.1)
8 4 0 (0) 4 (100)
10 1 0 (0) 1 (100)
Number of biopsy specimens 0.127
1 51 0 (0) 7 (100)
2 85 0 (0) 20 (100)
3 171 2 (7.4) 25 (92.6)
4 348 14 (6.7) 195 (93.3)
5 117 16 (12.6) 111 (87.4)
6 113 61 (14.1) 372 (85.9)
7 0 3 (10.3) 26 (89.7)
8 4 4 (12.1) 29 (87.9)
10 1 0 (0) 5 (100)
Average size of tumor fragements (cm) 0.397
≤0.15 110 9 (8.2) 101 (91.8)
>0.15 ≤ 0.20 417 54 (12.9) 363 (87.1)
>0.20 ≤ 0.25 291 31 (10.7) 260 (89.3)
>0.25 72 6 (8.3) 66 (91.7)
Tumor tissue proportion of tumor fragments (%) 0.825
≤30 132 13 (9.8) 119 (90.2)
>30 ≤ 50 324 40 (12.3) 284 (87.7)
>50 ≤ 70 289 30 (10.4) 259 (89.6)
>70 145 17 (11.7) 128 (88.3)

“n” refers to the number of cases

*P <0.05